3.44
price down icon0.58%   -0.02
after-market After Hours: 3.48 0.04 +1.16%
loading

Larimar Therapeutics Inc Stock (LRMR) Forecast

The Larimar Therapeutics Inc (LRMR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $279.41, representing a +8,023% increase from the current price of $3.44. The highest analyst price target is $280.52, and the lowest is $278.31.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LRMR Price Target
Average 250.18 (+7,173% Upside)
loading

Is Larimar Therapeutics Inc (LRMR) A Buy Now?

Oscillators
Name Value Action
RSI(14) 54.02 Neutral
STOCH(9,6) 49.81 Neutral
STOCHRSI(14) 22.95 Neutral
MACD(12,26) 0.167 Sell
ADX(14) 28.36 Buy
William %R -62.98 Neutral
CCI(14) -13.38 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
3.567
Sell
3.5114
Sell
MA20
3.4425
Sell
3.4046
Buy
MA50
2.9475
Buy
3.0891
Buy
MA100
2.5838
Buy
3.0899
Buy
MA200
3.8678
Sell
3.9185
Sell
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, LRMR could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on LRMR, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 54.02 indicates that LRMR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 49.81 indicates that LRMR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 22.95 indicates that LRMR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 28.36 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -13.38 indicates that LRMR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term LRMR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Larimar Therapeutics Inc financial reports and earnings history, Larimar Therapeutics Inc (LRMR) stock could reach $531.34 by 2030, $264.15 by 2040 and $862.21 by 2050. See the projected annual prices until 2050 of the Larimar Therapeutics Inc stock below:

  • Larimar Therapeutics Inc (LRMR) is expected to reach an average price of $81.93 in 2035, with a high prediction of $92.54 and a low estimate of $82.38. This indicates an $2,282% rise from the last recorded price of $3.44.
  • Larimar Therapeutics Inc (LRMR) stock is projected to chart a bullish course in 2040, with an average price target of $252.75, representing an $7,248% surge from its current level. The forecast ranges from a conservative $253.05 to a sky-high $264.15.
  • Our analysts predict Larimar Therapeutics Inc (LRMR) to jump 14,654% by 2045, soaring from $507.72 to an average price of $507.53, potentially reaching $522.21. While $507.72 is the low estimate, the potential upside is significant.
  • Larimar Therapeutics Inc (LRMR) stock is expected to climb by 2050, reaching an average of $843.13, a $24,410% jump from its current level. However, a wide range of estimates exists, with high and low targets of $862.21 and $843.75, respectively, highlighting the market's uncertainty.

Larimar Therapeutics Inc Stock (LRMR) Year by Year Forecast

Larimar Therapeutics Inc Stock (LRMR) Price Forecast for 2025

Larimar Therapeutics Inc Stock (LRMR) is expected to reach an average price of $217.29 in 2025, with a high prediction of $284.42 and a low estimate of $150.15. This indicates an +6,216% rise from the last recorded price of $3.44.
Month Average Low High Change from today's price
September, 2025 $278.31 $278.31 $280.52 +7,990%
October, 2025 $270.12 $270.73 $275.26 +7,752%
November, 2025 $262.13 $263.30 $263.85 +7,520%
December, 2025 $252.16 $253.67 $260.38 +7,230%

Larimar Therapeutics Inc Stock (LRMR) Price Forecast for 2026

The predicted value for Larimar Therapeutics Inc (LRMR) in 2026 is set at an average of $221.51. Estimates vary from a peak of $249.49 to a trough of $193.52, indicating an +6,339% surge from the present price of $3.44.
Month Average Low High Change from today's price
January, 2026 $244.17 $246.98 $249.49 +6,998%
February, 2026 $241.20 $240.56 $242.28 +6,912%
March, 2026 $236.14 $237.24 $236.27 +6,765%
April, 2026 $230.40 $232.21 $234.59 +6,598%
May, 2026 $226.10 $227.24 $228.83 +6,473%
June, 2026 $225.03 $225.20 $225.19 +6,442%
July, 2026 $219.55 $221.12 $222.98 +6,282%
August, 2026 $219.52 $219.85 $220.71 +6,281%
September, 2026 $210.13 $211.06 $218.03 +6,008%
October, 2026 $205.73 $206.57 $208.90 +5,881%
November, 2026 $196.97 $197.30 $201.07 +5,626%
December, 2026 $193.36 $193.52 $194.84 +5,521%

Larimar Therapeutics Inc Stock (LRMR) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Larimar Therapeutics Inc (LRMR) is $164.71, with a high forecast of $191.97 and a low forecast of $137.45. This indicates an +4,688% increase from the last price of $3.44.
Month Average Low High Change from today's price
January, 2027 $187.07 $188.85 $191.97 +5,338%
February, 2027 $184.63 $184.73 $185.15 +5,267%
March, 2027 $177.54 $179.57 $182.98 +5,061%
April, 2027 $174.32 $174.66 $176.27 +4,967%
May, 2027 $169.64 $169.94 $173.06 +4,832%
June, 2027 $168.05 $168.14 $170.69 +4,785%
July, 2027 $162.93 $163.23 $166.40 +4,636%
August, 2027 $158.48 $158.70 $161.64 +4,507%
September, 2027 $152.85 $152.96 $156.44 +4,343%
October, 2027 $148.60 $148.60 $151.61 +4,220%
November, 2027 $143.47 $143.52 $146.94 +4,071%
December, 2027 $136.97 $137.45 $142.06 +3,882%

Larimar Therapeutics Inc Stock (LRMR) Price Forecast for 2028

In 2028, Larimar Therapeutics Inc (LRMR) is projected to reach an average price of $102.17, with a high projection of $134.24 and a low estimate of $70.09. This indicates an +2,870% rise from the last price of $3.44.
Month Average Low High Change from today's price
January, 2028 $131.25 $131.61 $134.24 +3,715%
February, 2028 $125.74 $125.91 $129.33 +3,555%
March, 2028 $119.30 $119.61 $124.22 +3,368%
April, 2028 $114.36 $114.56 $117.99 +3,224%
May, 2028 $106.83 $107.01 $113.03 +3,005%
June, 2028 $101.77 $101.91 $105.59 +2,858%
July, 2028 $94.38 $95.83 $100.07 +2,644%
August, 2028 $89.19 $89.21 $92.93 +2,493%
September, 2028 $85.16 $85.50 $87.42 +2,376%
October, 2028 $79.83 $80.15 $83.59 +2,221%
November, 2028 $74.42 $74.57 $77.77 +2,063%
December, 2028 $70.02 $70.09 $72.96 +1,935%

Larimar Therapeutics Inc Stock (LRMR) Price Forecast for 2029

The 2029 price forecast for Larimar Therapeutics Inc Stock (LRMR) is $179.22 on average, with a high prediction of $356.82 and a low estimate of $1.6186. This represents an +5,110% increase from the previous price of $3.44.
Month Average Low High Change from today's price
January, 2029 $62.53 $62.95 $68.58 +1,718%
February, 2029 $57.78 $58.08 $61.24 +1,580%
March, 2029 $52.42 $52.90 $56.14 +1,424%
April, 2029 $48.66 $48.93 $51.14 +1,315%
May, 2029 $42.80 $43.07 $47.00 +1,144%
June, 2029 $36.64 $36.83 $40.47 +965.09%
July, 2029 $30.56 $30.81 $35.04 +788.29%
August, 2029 $22.98 $23.89 $28.64 +567.94%
September, 2029 $11.57 $12.34 $21.06 +236.48%
October, 2029 $9.2647 $9.2647 $9.5168 +169.32%
November, 2029 $5.7526 $6.1026 $7.9167 +67.23%
December, 2029 $372.66 $1.6186 $356.82 +10,733%

Larimar Therapeutics Inc Stock (LRMR) Price Forecast for 2030

Larimar Therapeutics Inc Stock (LRMR) is expected to reach an average price of $505.87 in 2030, with a high forecast of $606.00 and a low forecast of $405.75. This signifies an +14,606% surge from the last price of $3.44.
Month Average Low High Change from today's price
January, 2030 $550.06 $405.75 $531.34 +15,890%
February, 2030 $567.28 $554.72 $555.41 +16,391%
March, 2030 $590.40 $571.94 $584.15 +17,063%
April, 2030 $598.11 $599.78 $590.19 +17,287%
May, 2030 $597.81 $601.27 $606.00 +17,278%
June, 2030 $587.09 $590.98 $594.55 +16,967%
July, 2030 $563.47 $577.00 $581.53 +16,280%
August, 2030 $557.50 $560.03 $558.63 +16,106%
September, 2030 $476.79 $504.15 $497.33 +13,760%
October, 2030 $461.23 $489.17 $482.15 +13,308%
November, 2030 $517.19 $473.10 $471.25 +14,934%
December, 2030 $521.59 $525.91 $515.37 +15,062%
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):